CD79A and COVID-19: In most of these milk samples, SARS-CoV-2-specific antibodies were present (76% IgA and 80% IgG), with higher concentrations of the first class and, consequently, BM produced by mothers with COVID-19 acquires the in vitro ability of viral neutralization (62% of cases) [11].